About this Event
We are excited to inform you of Convatec’s upcoming New Zealand launch evening for our range of intermittent catheters on 25 June 2024.
We will have GentleCath™ Glide and Cure Medical® ranges available on the night for you to handle and discuss with your peers as well as an opportunity to hear from the developers from CURE Medical.
- GentleCath™ Glide with FeelClean™ Technology integrates hydrophilic properties into the catheter and is designed to protect the urethra from damage.
- Cure Medical® range of catheters feature smooth, polished eyelets for comfort.
Please advise us if there are any dietary requirements you have that we need to be made aware of.
Please do not hesitate to contact me if you require any further information
Michelle Humphries
Mob: 021328482
Special guest speakers:
John Anderson – Managing Director, Cure Medical
John worked at Mentor Corp., as the Global Director of Marketing from 2000-2006, selling the Self-Cath brand in the USA and expanding into Europe. During this time Mentor was number one in volume in the USA and growing in Europe. It was here John the importance of listening to customers, which included clinicians, end users and business partners across many countries.
In 2006, Mentor was acquired by Coloplast and after a 6-month period John was approached by an end user who had a severe C6 spinal cord injury and wanted to make better products and give back to the community. In 2007, Cure Medical started, supporting research for a cure. To be successful, Cure Medical would need to apply research learnings, create products that are an upgrade to what was currently available, and price in a way that would be affordable. The goal was to someday ship 2 million catheters a year. To deliver an upgrade, Cure Medical created special machines to make the smoothest eyelets for safety and comfort. They avoided carcinogens in the plastic and decided to be latex free, as one group that tends to use catheters are people born with Spina Bifida, and this group is more susceptible to latex allergies. Cure Medical continued to listen to clinicians, end users and business partners. The cosmetic looking Twist catheter, and the minimal waste Ultra brands are the result of comments from customers.
In 2021, Cure Medical became part of Convatec to bring high quality catheters with a good price to countries like (Australia and) New Zealand, where an upgraded product will be appreciated by customers. Cure Medical has become number one in volume in the USA, and supplies more catheters in a week, than they had even dreamed of suppling in a year! Clinicians and end users that try Cure, stay with the upgrade, that is Cure!
Christopher Sellwood – Convatec Senior National Commercial Director
Christopher Sellwood manages the Continence Care sales and marketing efforts in the US. Prior to that, Christopher was the Vice President of Sales for Cure Medical. Previously, he had extended tenure in the urology space, selling urinary catheters and urologic implants at both American Medical Systems (now Boston Scientific) and Mentor Urology (now Coloplast). Christopher has worked in the urologic space since 1996.
Beau Alford – Convatec Senior Sales Manager
Beau has spent the last 16 years in urology focused on intermittent catheters. He has been with Cure/Convatec for 10 years focused on promoting Cure and growing brand awareness. Beau works with adult and paediatric urology, Spinal Cord injury hospitals, and paediatric specialty clinics educating clinicians on the Cure portfolio. He currently manages the U.S. distribution channel focusing on pricing, product education, and supporting our distribution customers.
Event Venue & Nearby Stays
Trinity Wharf Tauranga, 51 Dive Crescent, Tauranga, New Zealand